This article was originally published in The Gray Sheet
Executive SummaryGroup purchasing organization signs multi-source agreements with Tyco/Kendall covering standard needles and syringes, safety needles, pre-filled syringes and other products. Effective Jan. 1, 2003, the contracts include the Monoject and Magellan brands. Separately, the firm signs a "new technology" contract with St. Jude to provide atrial fibrillation suppression technology, including the Identity and Integrity pacemakers...
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.